Chevron Corporation vs Enterprise Products Partners L. — Stock Comparison
Q·Score Breakdown
6.4
Neutral
Overall
5.6
Neutral
Quality
Health
Growth
Valuation
Sentiment
CVX
Clean balance sheet with low leverage (0.2× debt-to-equity).
⚠ earnings contracting 44% year-over-year.
EPD
Forward P/E of 12.1× is low relative to sector peers.
⚠ revenue declining 7% year-over-year.
Analyst Consensus
BUY
Target $213.30 (+11.9%)
23 analysts
HOLD
Target $40.45 (+6.4%)
20 analysts
Fundamentals
CVX
EPD
33.2×
Trailing P/E
14.1×
16.1×
Forward P/E
12.1×
5.9%
Profit Margin
11.4%
42.4%
Gross Margin
14.3%
—
ROE
—
3.5%
Revenue Growth
-6.7%
-44.4%
Earnings Growth
6.5%
0.59
Beta
0.53
—
Price / Book
—
$379.7B
Market Cap
$82.2B
$134 – $215
52-Week Range
$30 – $40
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →